We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

QUIDEL

Develops, manufactures and markets rapid diagnostic tests at the point-ofcare (POC) that focus on infectious diseases... read more Featured Products: More products

Download Mobile App




Informatics Solution Elevates Laboratory Efficiency and Patient Care

By LabMedica International staff writers
Posted on 11 Mar 2025
Print article
Image: The Results Manager System (Photo courtesy of QuidelOrtho)
Image: The Results Manager System (Photo courtesy of QuidelOrtho)

QuidelOrtho Corporation (San Diego, CA, USA) has introduced the QuidelOrtho Results Manager System, a cutting-edge informatics solution designed to meet the increasing demands of modern laboratories. This system offers a streamlined, user-friendly interface for community hospitals and point-of-care settings, enhancing the informatics capabilities across QuidelOrtho's broad range of diagnostic tools. The QuidelOrtho Results Manager System provides continuous tracking of instruments and assays, simplifying workflows with features like auto-verification and intuitive rule-writing tools.

The system ensures easy integration with multiple instruments and supports unlimited concurrent users, while accelerating results delivery with quicker turnaround times. Its design facilitates simple installation and delivers immediate value, making it a cost-efficient solution for laboratories. Early users involved in trials have praised the system for its ease of use and adaptability. Key features such as the Master Data Module for quick assay configuration and a drag-and-drop interface help reduce errors, improve staff productivity, and enhance patient care. Integrated quality control (QC) tools and real-time insights further optimize laboratory processes, allowing staff to concentrate on critical tasks. QuidelOrtho is now launching the QuidelOrtho Results Manager System globally.

"The Results Manager system addresses the critical challenges laboratories face today—rising test volumes, staffing shortages and increasing complexity—while maintaining a focus on high-quality patient care," said Bryan Hanson, Senior Vice President, Labs and Transfusion Medicine Business Units, QuidelOrtho. "We're proud to deliver an intuitive, agile solution that supports our customers' evolving needs."

Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Multi-Function Pipetting Platform
apricot PP5
New
Total 25-Hydroxyvitamin D₂ & D₃ Assay
Total 25-Hydroxyvitamin D₂ & D₃ Assay

Print article

Channels

Molecular Diagnostics

view channel
Image: The Mirvie RNA platform predicts pregnancy complications months before they occur using a simple blood test (Photo courtesy of Mirvie)

RNA-Based Blood Test Detects Preeclampsia Risk Months Before Symptoms

Preeclampsia remains a major cause of maternal morbidity and mortality, as well as preterm births. Despite current guidelines that aim to identify pregnant women at increased risk of preeclampsia using... Read more

Immunology

view channel
Image: The cancer stem cell test can accurately choose more effective treatments (Photo courtesy of University of Cincinnati)

Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer

Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more

Microbiology

view channel
Image: The lab-in-tube assay could improve TB diagnoses in rural or resource-limited areas (Photo courtesy of Kenny Lass/Tulane University)

Handheld Device Deliver Low-Cost TB Results in Less Than One Hour

Tuberculosis (TB) remains the deadliest infectious disease globally, affecting an estimated 10 million people annually. In 2021, about 4.2 million TB cases went undiagnosed or unreported, mainly due to... Read more

Technology

view channel
Image: Schematic illustration of the chip (Photo courtesy of Biosensors and Bioelectronics, DOI: https://doi.org/10.1016/j.bios.2025.117401)

Pain-On-A-Chip Microfluidic Device Determines Types of Chronic Pain from Blood Samples

Chronic pain is a widespread condition that remains difficult to manage, and existing clinical methods for its treatment rely largely on self-reporting, which can be subjective and especially problematic... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.